Peptide Therapeutics MarketThe global peptide therapeutics market is on a strong growth trajectory, with sales projected to ...

The global leukemia therapeutics treatment market has seen considerable growth, progressing from USD 14,504.8 million in 2022 to USD 15,246.7 million in 2023. With a projected compound annual growth ...

North America severe asthma market is set for growth, driven by high asthma prevalence, increased awareness, and advanced treatment options for severe cases. Ankush Nikam Future Market Insights, Inc.

The global Pharmaceutical Filtration Market is set to experience robust growth over the next decade. Currently valued at US$ ...

Neurotrophins are a group of proteins that play a critical role in the health and function of our nervous system. They are ...

The USA's proteomics market grows steadily, driven by NIH funding in personalized medicine, while Canada is expected to grow ...

Maxim Group analyst Jason McCarthy maintained a Buy rating on Capricor Therapeutics (CAPR – Research Report) yesterday and set a price target of $25.00. Discover the latest stocks recommended by ...

In this article, we are going to take a look at where Autolus Therapeutics plc (NASDAQ:AUTL) stands against the other best biotech penny stocks to invest in now. Goldman Sachs has spotlighted an ...

Begin your TipRanks Premium journey today. Neumora Therapeutics, Inc. (NMRA) Company Description: Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing ...

The skincare treatment market is grow USD 35,237.24 million by 2034, driven by social media influence, aging population, and technological advancements. Ankush Nikam Future Market Insights, Inc. +91 ...

On Thursday, H.C. Wainwright adjusted its price target on TransCode Therapeutics Inc (NASDAQ: RNAZ) significantly upwards, from $3.00 to $20.00, while maintaining a ...

Novartis is set to develop and commercialise a range of digital therapeutics for patients with substance and opioid use disorders as it expands its work with Pear Therapeutics through a deal with ...